Real-world evidence during health emergencies: patient-centric uses and future trends

Written by Dr. Kelly H. Zou (Upjohn Division, Pfizer Inc)

Dr. Kelly H. Zou In this original opinion piece, Dr. Kelly H. Zou, Vice President and Head of Medical Analytics Insights, R&D and Medical, Upjohn Division, Pfizer Inc (NY, USA), discuss the relevance of real-world evidence (RWE) in addressing noncommunicable diseases (NCDs) and offers ideas on a future vision for healthcare in which the community can harness emerging trends in RWE to support impact for individual patients and the public health. Noncommunicable diseases (NCDs) are the leading cause of death around the world, affecting more people each year than all other causes combined [1]. These chronic diseases – including cardiovascular...

To view this content, please register now for access

It's completely free